Hierarchical phosphorylation of the translation inhibitor 4E-BP1

  1. Anne-Claude Gingras1,7,
  2. Brian Raught1,7,
  3. Steven P. Gygi2,8,
  4. Anna Niedzwiecka3,
  5. Mathieu Miron1,
  6. Stephen K. Burley4,
  7. Roberto D. Polakiewicz5,
  8. Aleksandra Wyslouch-Cieszynska6,
  9. Ruedi Aebersold2,9, and
  10. Nahum Sonenberg1,10
  1. 1Department of Biochemistry and McGill Cancer Centre, McGill University, Montréal, Québec H3G 1Y6, Canada; 2Department of Molecular Biotechnology, University of Washington, Seattle, Washington 98195-7730, USA; 3Department of Biophysics, Institute of Experimental Physics, Warsaw University, Warsaw PL 02-089, Poland; 4Laboratories of Molecular Biophysics, Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10021, USA; 5Cell Signaling Technology, Beverly, Massachusetts 01915, USA; 6Institute of Biochemistry and Biophysics, Polish Academy of Sciences, PL 02-106 Warsaw, Poland

Abstract

In most instances, translation is regulated at the initiation phase, when a ribosome is recruited to the 5′ end of an mRNA. The eIF4E-binding proteins (4E-BPs) interdict translation initiation by binding to the translation factor eIF4E, and preventing recruitment of the translation machinery to mRNA. The 4E-BPs inhibit translation in a reversible manner. Hypophosphorylated 4E-BPs interact avidly with eIF4E, whereas 4E-BP hyperphosphorylation, elicited by stimulation of cells with hormones, cytokines, or growth factors, results in an abrogation of eIF4E-binding activity. We reported previously that phosphorylation of 4E-BP1 on Thr 37 and Thr 46 is relatively insensitive to serum deprivation and rapamycin treatment, and that phosphorylation of these residues is required for the subsequent phosphorylation of a set of unidentified serum-responsive sites. Here, using mass spectrometry, we identify the serum-responsive, rapamycin-sensitive sites as Ser 65 and Thr 70. Utilizing a novel combination of two-dimensional isoelectric focusing/SDS-PAGE and Western blotting with phosphospecific antibodies, we also establish the order of 4E-BP1 phosphorylation in vivo; phosphorylation of Thr 37/Thr 46 is followed by Thr 70 phosphorylation, and Ser 65 is phosphorylated last. Finally, we show that phosphorylation of Ser 65 and Thr 70 alone is insufficient to block binding to eIF4E, indicating that a combination of phosphorylation events is necessary to dissociate 4E-BP1 from eIF4E.

Keywords

Footnotes

  • 7 These authors contributed equally to this work.

  • Present addresses: 8Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; 9Institute for Systems Biology, Seattle, WA 98105, USA.

  • 10 Corresponding author.

  • E-MAIL nsonen{at}med.mcgill.ca; FAX (514) 398-1287.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.912401.

    • Received May 17, 2001.
    • Accepted September 5, 2001.
| Table of Contents

Life Science Alliance